Wellington Management Group’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$543K	Buy	+42,359	New	+$540K	﹤0.01%	1766
2025 Q4	–	Sell	-44,529	Closed	-$769K	–	2029
2025 Q3	$769K	Buy	+44,529	New	+$548K	﹤0.01%	1825
2025 Q1	–	Sell	-699,814	Closed	-$8.16M	–	2022
2024 Q4	$8.16M	Buy	699,814 +55,051	+9%	+$859K	﹤0.01%	1251
2024 Q3	$13.2M	Sell	644,763 -137,011	-18%	-$3.16M	﹤0.01%	1088
2024 Q2	$17.5M	Sell	781,774 -3,380,355	-81%	-$80.5M	﹤0.01%	997
2024 Q1	$115M	Buy	4,162,129 +1,705,212	+69%	+$47.4M	0.02%	521
2023 Q4	$74.9M	Sell	2,456,917 -195,077	-7%	-$5.61M	0.01%	622
2023 Q3	$83.9M	Buy	2,651,994 +36,630	+1%	+$1.42M	0.02%	576
2023 Q2	$107M	Sell	2,615,364 -350,776	-12%	-$14.2M	0.02%	532
2023 Q1	$111M	Buy	2,966,140 +971,952	+49%	+$38.1M	0.02%	516
2022 Q4	$69.6M	Buy	1,994,188 +1,418,896	+247%	+$67.5M	0.01%	606
2022 Q3	$32.2M	Sell	575,292 -84,607	-13%	-$5.25M	0.01%	776
2022 Q2	$34.2M	Sell	659,899 -118,613	-15%	-$6.02M	0.01%	789
2022 Q1	$56.6M	Buy	778,512 +167,764	+27%	+$14.2M	0.01%	722
2021 Q4	$72.2M	Buy	610,748 +26,940	+5%	+$3.37M	0.01%	720
2021 Q3	$78.3M	Buy	583,808 +268,167	+85%	+$40.6M	0.01%	691
2021 Q2	$51.1M	Buy	+315,641	New	+$24.6M	0.01%	819